Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Galera Therapeutics enrolls patients for pancreatic cancer trial of GC4419 Galera Therapeutics said that it has wrapped up enrollment of patients for its phase 1b/2a safety and anti-cancer… bypharmanewsdailyJuly 14, 2020